Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?

Within 6 months of delivery, women who had gestational diabetes mellitus should be screened for type 2 diabetes with a fasting plasma glucose test and/or a 2-h postchallenge glycemia in a 75-g oral glucose tolerance test. However, not all women are screened. The objective of this study is to compare the screening test for type 2 diabetes done at 48 hours post-partum versus 8 weeks post-partum. The investigators want to measure the specificity, sensitivity, false and true predictive values of the screening test at 48 hours post-partum compared to the gold-standard.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gestational Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetes, Gestational Endocrine System Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Complications Type 2 Diabetes Urogenital Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Centre hospitalier universitaire de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Dx of gestational diabetes treated with insulin
To be in post-partum
Delivery of a baby of at least 37 weeks of gestation
Have signed the consent form

Exclusion criteria

History of glucose intolerance of diabetes before the pregnancy
Obstetrical pathology during pregnancy

Treatment and study plan

Oral Glucose Tolerance Test

Procedure

Subjects will have the Oral glucose tolerance test 48 hours post-partum and the same test 8 weeks post-partum.

Primary outcomes

Oral glucose tolerance test

Time frame: 8 weeks post partum

Sensitivity, specificity, true and false predictive values of the oral glucose tolerance test

Secondary outcomes

Acceptability of screening test

Time frame: 8 weeks post partum

Prefered moment to do the screening test (48 hours post partum or 8 weeks post partum)

Sponsors and collaborators

Lead sponsor

Université de Sherbrooke

Other

Registry information

Official study title

Is it Possible to Screen for Type 2 Diabetes at Day 2 Gestational Diabetes Mellitus Postpartum?

Acronym: DG4

Important dates

Study start: 2008
Primary completion: 2012
Study completion: 2013
First posted: Jun 16, 2009
Registry last updated: May 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting